Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MPA.0000000000000824 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to: Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis.
J Clin Oncol
January 2025
Joseph R. Habib, MD, Ammar A. Javed, MD, and Christopher L. Wolfgang, MD, PhD, New York University Grossman School of Medicine, New York, NY.
Reply to Lin et al.
Gastroenterology
January 2025
Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 100023, Beijing, P.R. China; Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, 100023, Beijing, P.R. China; National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, 100023, Beijing, P.R. China; State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 100023, Beijing, P.R. China. Electronic address:
Reply to Hilmi et al.
Gastroenterology
January 2025
NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
[Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells.
Oncol Rep
February 2025
Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blot data shown in Fig. 4 on p. 521 were strikingly similar to data that had already appeared in a pair of figures in a previously published article written by different authors at different research institutes in the journal .
View Article and Find Full Text PDFReply to letter to editor by Duo Yun, MD regarding our article, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
Surgery
December 2024
Department of Surgery, Osaka International Cancer Institute, Osaka, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!